SFS
RXRX icon

Sowell Financial Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Sowell Financial Services’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Buy
110,430
+38,022
+53% +$127K 0.01% 740
2026
Q1 		$222K Buy
72,408
+441
+0.6% +$1.7K 0.01% 983
2025
Q4 		$294K Buy
71,967
+17,300
+32% +$85.7K 0.01% 844
2025
Q3 		$267K Buy
+54,667
New +$287K 0.01% 859

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sowell Financial Services's RXRX Position: Q2 2026 in Review

Sowell Financial Services increased its Recursion Pharmaceuticals (RXRX) stake by 53% in Q2 2026, buying an estimated $127K and bringing the position to 110,430 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #740.

Sowell Financial Services first reported a position in RXRX in Q3 2025 and has held it in 4 quarters since. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Sowell Financial Services held 110,430 shares of Recursion Pharmaceuticals worth $405K as of Q2 2026.
  • Sowell Financial Services bought 38,022 Recursion Pharmaceuticals shares in Q2 2026, an estimated $127K.
  • Recursion Pharmaceuticals made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #740 holding.
  • Sowell Financial Services first reported a position in Recursion Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.